Literature DB >> 22035141

Ethical aspects of the expansion of neonatal screening programme due to technological advances.

David Elliman1.   

Abstract

Many countries are considering the expansion of their newborn bloodspot screening programmes. Whereas some countries screen for very few conditions, others are planning to screen for dozens. While advances in technology may facilitate this expansion, they must not lead it at the expense of considerations of the possible harms of this expansion. This article reviews some of the potential disbenefits of this expansion and outlines the ethical issues that should be considered.

Mesh:

Year:  2012        PMID: 22035141     DOI: 10.1515/CCLM.2011.761

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  2 in total

1.  Neuromuscular disease: Muscular dystrophy--something new on God's green earth?

Authors:  Alessandra Ferlini
Journal:  Nat Rev Neurol       Date:  2012-03-27       Impact factor: 42.937

Review 2.  Review of Current International Decision-Making Processes for Newborn Screening: Lessons for Australia.

Authors:  Selina Carolyne Metternick-Jones; Karla Jane Lister; Hugh J S Dawkins; Craig Anthony White; Tarun Stephen Weeramanthri
Journal:  Front Public Health       Date:  2015-09-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.